이상반응 보고
VAERS ID | 1188632 |
---|---|
성별 | 알 수 없음 |
나이 | |
주 코드 | WI |
제약회사 | JANSSEN |
로트 번호 | 1805022 |
예방접종 횟수 | |
접종일 | |
발병일 | 2021-03-01 |
상태 |
증상
- 모유를 통한 노출(Exposure via breast milk)
이환 중 질병
지병
Comments: Unknown
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
EXPOSURE VIA BREAST MILK; This spontaneous report received from a parent concerned a patient of unspecified age and sex.
The patient's weight, height, and medical history were not reported.
The patient's parent received covid-19 vaccine ad26.
cov2.
s (suspension for injection, transmammary, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for an unspecified indication.
No concomitant medications were reported.
On MAR-2021, the subject experienced exposure via breast milk.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The outcome of exposure via breast milk was not reported.
This report was non-serious.
Version created to amend previously reported information on 10-Mar-2021.
Upon review the following information was amended: Event of Maternal exposure during breast feeding was changed to Exposure via breast milk.
; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is assessed non serious.